These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 19476562)
1. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan. Chang WL; Sheu BS; Cheng HC; Yang YJ; Yang HB; Wu JJ J Gastroenterol Hepatol; 2009 Jul; 24(7):1230-5. PubMed ID: 19476562 [TBL] [Abstract][Full Text] [Related]
2. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan. Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027 [TBL] [Abstract][Full Text] [Related]
4. Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics? Branquinho D; Almeida N; Gregório C; Cabral JE; Casela A; Donato MM; Tomé L BMC Gastroenterol; 2017 Feb; 17(1):31. PubMed ID: 28202013 [TBL] [Abstract][Full Text] [Related]
5. High incidence of antibiotic resistance amongst isolates of Garvey E; Rhead J; Suffian S; Whiley D; Mahmood F; Bakshi N; Letley D; White J; Atherton J; Winter JA; Robinson K J Med Microbiol; 2023 Nov; 72(11):. PubMed ID: 37962209 [No Abstract] [Full Text] [Related]
6. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies. Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111 [TBL] [Abstract][Full Text] [Related]
7. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Nista EC; Candelli M; Zocco MA; Cremonini F; Ojetti V; Finizio R; Spada C; Cammarota G; Gasbarrini G; Gasbarrini A Am J Gastroenterol; 2006 Sep; 101(9):1985-90. PubMed ID: 16968503 [TBL] [Abstract][Full Text] [Related]
8. Clarithromycin-Based Triple Therapy is Still Useful as an Initial Treatment for Miftahussurur M; Cruz M; Subsomwong P; Jiménez Abreu JA; Hosking C; Nagashima H; Akada J; Yamaoka Y Am J Trop Med Hyg; 2017 May; 96(5):1050-1059. PubMed ID: 28193745 [TBL] [Abstract][Full Text] [Related]
9. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Molina-Infante J; Perez-Gallardo B; Fernandez-Bermejo M; Hernandez-Alonso M; Vinagre G; Dueñas C; Mateos-Rodriguez JM; Gonzalez-Garcia G; Abadia EG; Gisbert JP Aliment Pharmacol Ther; 2010 May; 31(10):1077-84. PubMed ID: 20180787 [TBL] [Abstract][Full Text] [Related]
10. Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation. Dekhnich N; Ivanchik N; Kozlov R; Alimov A; Steshits A; Kirsov P; Pandav K Helicobacter; 2018 Dec; 23(6):e12545. PubMed ID: 30324756 [TBL] [Abstract][Full Text] [Related]
11. Clarithromycin-amoxycillin-containing triple therapy: a valid empirical first-line treatment for Helicobacter pylori eradication in Hong Kong? Hung IF; Chan P; Leung S; Chan FS; Hsu A; But D; Seto WK; Wong SY; Chan CK; Gu Q; Tong TS; Cheung TK; Chu KM; Wong BC Helicobacter; 2009 Dec; 14(6):505-11. PubMed ID: 19889067 [TBL] [Abstract][Full Text] [Related]
12. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study. Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574 [TBL] [Abstract][Full Text] [Related]
13. Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland. Karczewska E; Wojtas-Bonior I; Sito E; Zwolińska-Wcisło M; Budak A Pharmacol Rep; 2011; 63(3):799-807. PubMed ID: 21857091 [TBL] [Abstract][Full Text] [Related]
14. ANTIBIOTIC RESISTANCE SURVEILLANCE OF HELICOBACTER PYLORI AT THE BIOBÍO REGION (CHILE) IN A DECADE. Parra-Sepúlveda C; Merino JS; Sáez-Carrillo K; González C; García-Cancino A Arq Gastroenterol; 2019; 56(4):361-366. PubMed ID: 31721972 [TBL] [Abstract][Full Text] [Related]
15. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains. Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326 [TBL] [Abstract][Full Text] [Related]
17. Third-line rescue therapy with levofloxacin after two H. pylori treatment failures. Gisbert JP; Castro-Fernández M; Bermejo F; Pérez-Aisa A; Ducons J; Fernández-Bermejo M; Bory F; Cosme A; Benito LM; López-Rivas L; Lamas E; Pabón M; Olivares D; Am J Gastroenterol; 2006 Feb; 101(2):243-7. PubMed ID: 16454825 [TBL] [Abstract][Full Text] [Related]
18. Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades. Lu HH; Lai FP; Lo HY; Sheu BS; Yang YJ Helicobacter; 2019 Oct; 24(5):e12633. PubMed ID: 31295754 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital. Dib J; Alvarez B; Mendez L; Cruz ME Arab J Gastroenterol; 2013 Sep; 14(3):123-5. PubMed ID: 24206741 [TBL] [Abstract][Full Text] [Related]